IPHA_logo_main_version_h100IPHA_logo_main_version_h100IPHA_logo_main_version_h100IPHA_logo_main_version_h100
  • Home
  • News
  • Events
    • IPHA Forum
    • IPHA Conference
    • All other events
  • Publications
    • 2025
      • EFPIA Patients Wait Indicator 2024
      • IPHA Position Paper on Fairer and Faster Access to Medicine
    • 2024
      • EFPIA Patient WAIT Indicator Survey
      • Clinical Trials Agreement
      • IPHA Clinical Trials Activity Comparison Report
      • Making Ireland a European Leader in Clinical Research
    • 2023
      • Achieving Universal Access to New Medicines for Irish Patients
      • Oireachtas briefing
      • IPHA Policy on Supply Outside Reimbursement Final
      • IPHA Self-Care Infographic
    • 2022
      • IPHA reimbursement timelines analysis 2022
      • Factors Affecting the Location of Biopharmaceutical Investments and Implications for European Policy Priorities
      • IHE Cancer Care Comparator Study
      • White Paper on Enterprise
    • 2021
      • Clinical Trials Survey
      • Cell and Gene Pathfinder Study
      • IPHA Codes of Practice
    • Pre 2020
      • BioPharma Ambition
      • Manifesto for Better Health
      • Innovation and the IP Framework
      • Self-Care: Taking Charge of Your Health
      • Vaccines For Life
      • Perspectives on Ireland’s Medicines Future
  • Code
    • Codes of Practice
    • Transfers of Value
    • Mandatory notification regarding Advisory Board Meetings
    • IPHA Code Training
    • Complaints
  • Clinical and Regulatory
    • Regulation for Innovation
    • Clinical Trials
    • Medicine Safety
    • Regulatory Science Ireland
    • Counterfeit Medicines
  • Self-Care
  • About Us
    • Members
    • Board of Directors
    • Our Team
    • Affiliates Programme
    • Job Opportunities
  • Home
  • News
  • Events
    • IPHA Forum
    • IPHA Conference
    • All other events
  • Publications
    • 2025
      • EFPIA Patients Wait Indicator 2024
      • IPHA Position Paper on Fairer and Faster Access to Medicine
    • 2024
      • EFPIA Patient WAIT Indicator Survey
      • Clinical Trials Agreement
      • IPHA Clinical Trials Activity Comparison Report
      • Making Ireland a European Leader in Clinical Research
    • 2023
      • Achieving Universal Access to New Medicines for Irish Patients
      • Oireachtas briefing
      • IPHA Policy on Supply Outside Reimbursement Final
      • IPHA Self-Care Infographic
    • 2022
      • IPHA reimbursement timelines analysis 2022
      • Factors Affecting the Location of Biopharmaceutical Investments and Implications for European Policy Priorities
      • IHE Cancer Care Comparator Study
      • White Paper on Enterprise
    • 2021
      • Clinical Trials Survey
      • Cell and Gene Pathfinder Study
      • IPHA Codes of Practice
    • Pre 2020
      • BioPharma Ambition
      • Manifesto for Better Health
      • Innovation and the IP Framework
      • Self-Care: Taking Charge of Your Health
      • Vaccines For Life
      • Perspectives on Ireland’s Medicines Future
  • Code
    • Codes of Practice
    • Transfers of Value
    • Mandatory notification regarding Advisory Board Meetings
    • IPHA Code Training
    • Complaints
  • Clinical and Regulatory
    • Regulation for Innovation
    • Clinical Trials
    • Medicine Safety
    • Regulatory Science Ireland
    • Counterfeit Medicines
  • Self-Care
  • About Us
    • Members
    • Board of Directors
    • Our Team
    • Affiliates Programme
    • Job Opportunities
  • Home
  • About Us
  • Contact Us

Membership

  • Home
  • About Us
  • Membership
The IPHA represents the international research-based pharmaceutical industry in Ireland and comprises of member companies who are responsible for developing, manufacturing and bringing innovative medicines to Irish patients. For further information on our members, please click on company name below:

A Menarini Pharmaceuticals Ireland Ltd


AbbVie Limited


Alliance Pharmaceuticals Ireland


Almirall Ltd


Alimera Sciences Europe Limited


Amgen Ireland Limited


Astellas Pharma Ltd


Bayer Consumer Health


Bayer Limited


Biogen Idec (Ireland) Ltd


Boehringer Ingelheim Ireland Limited


Bristol-Myers Squibb Pharmaceuticals uc


Chugai Pharma UK Ltd


Daiichi Sankyo Ireland Ltd.


Eisai Limited


Eli Lilly & Company (Ireland) Ltd


Gilead Sciences Ireland UC


GlaxoSmithKline


Haleon 


Ipsen Pharmaceuticals Limited


Johnson & Johnson Innovative Medicine


Jazz Pharmaceuticals


LEO Pharma


Lundbeck (Ireland) Ltd


Merck


MSD


Mundipharma Pharmaceuticals Company


Novartis Ireland Ltd


Novo Nordisk Limited


McNeil Healthcare


Organon Pharma BV


Otsuka Pharmaceuticals (UK) Ltd


Perrigo


Pfizer Healthcare Ireland


Reckitt


Roche Products (Ireland) Limited


Sanofi Ltd


Servier Laboratories (Ireland) Limited


Takeda Products Ireland Ltd.


Tillotts Pharma Ltd


UCB

Terms and Conditions    |    Privacy Statement   |   Sitemap    |    Cookies


Registered Number: 254776    |    Registered Address: 7 Clanwilliam Terrace, Dublin 2, D02 CC64 Ireland   |  Email: info@ipha.ie

© 2024 IPHA